Last updated 2026-08-22
- Raised Undisclosed Round led by StartUp Health, Sep 2023
Total raised
—
Stage
—
Founded
2020
Headcount
—
HQ
Rishon LeZion, Israel
Sector
Clinics/Outpatient Services
About
Levicure Ltd. is an Israeli startup focused on providing an effective oral treatment for type 1 diabetes mellitus (T1DM). The company's therapy involves a combination of three FDA-approved molecules, secured by an extensive patent portfolio. This innovative therapy aims to facilitate remission of T1DM by restoring insulin production, stabilizing blood glucose levels, and significantly decreasing exogenous insulin demands, potentially leading to complete insulin withdrawal in some cases.
Funding history · 1 round · — total
2023-09
Undisclosed Round
Undisclosed
★ StartUp Health
Q&A
- What is Levicure Ltd.'s primary focus?
- Levicure Ltd. is an Israeli startup focused on developing an effective oral treatment for type 1 diabetes mellitus (T1DM).
- When was Levicure Ltd. founded?
- Levicure Ltd. was founded in 2020.
- Where is Levicure Ltd. headquartered?
- Levicure Ltd. is headquartered in Rishon LeZion, Israel.
- What is the core technology behind Levicure Ltd.'s therapy for T1DM?
- Levicure Ltd.'s therapy for T1DM involves a combination of three FDA-approved molecules, secured by an extensive patent portfolio.
- What are the aims of Levicure Ltd.'s innovative therapy for T1DM?
- The therapy aims to facilitate remission of T1DM by restoring insulin production, stabilizing blood glucose levels, and significantly decreasing exogenous insulin demands, potentially leading to complete insulin withdrawal in some cases.
- What is Levicure Ltd.'s primary sector?
- Levicure Ltd.'s primary sector is Clinics/Outpatient Services.
Sectors & technology
Primary sector
Clinics/Outpatient Services
Target customers
Business model
Pharmaceuticals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | levicure.com |
|---|
Identifiers & details
| Founded | 2020 |
|---|